Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
AstraZeneca
AZN
$257B
| $99.1M | 0.13% |
539,190
+201,109
| +59% | +$35.3M |
|
177
Occidental Petroleum
OXY
$61.3B
| $98.2M | 0.12% |
2,389,106
+227,592
| +11% | +$9.5M |
|
178
Snowflake
SNOW
$115B
| $97.1M | 0.12% |
442,699
+322,292
| +268% | +$78.7M |
|
179
CRH
CRH
$63.2B
| $97.1M | 0.12% |
777,813
-447,178
| -37% | -$53.3M |
|
180
Credo Technology Group
CRDO
$43B
| $96.9M | 0.12% |
+673,370
| New | +$104M |
|
181
Norwegian Cruise Line
NCLH
$7.92B
| $96.6M | 0.12% |
4,325,756
+1,554,695
| +56% | +$32.8M |
|
182
McDonald's
MCD
$192B
| $95.5M | 0.12% |
312,358
+241,688
| +342% | +$74M |
|
183
PUT
JPMorgan Chase
JPM
$935B
| $95.3M | 0.12% |
295,900
+9,900
| +3% | +$3.07M |
|
184
PUT
CrowdStrike
CRWD
$195B
| $95.2M | 0.12% |
812,400
+212,800
| +35% | +$27.1M |
|
185
Sun Communities
SUI
$14.8B
| $95.1M | 0.12% |
767,190
+463,312
| +152% | +$58M |
|
186
Veeva Systems
VEEV
$40.3B
| $94.9M | 0.12% |
424,944
+423,219
| +24,534% | +$112M |
|
187
PUT
KraneShares CSI China Internet ETF
KWEB
$5.28B
| $94.2M | 0.12% |
2,765,800
+328,300
| +13% | +$12.6M |
|
188
CALL
BILL Holdings
BILL
$4.76B
| $94.2M | 0.12% |
1,726,700
+802,400
| +87% | +$41.2M |
|
189
PUT
Mastercard
MA
$509B
| $93.2M | 0.12% |
163,300
-24,600
| -13% | -$13.8M |
|
190
Lowe's Companies
LOW
$121B
| $92.7M | 0.12% |
384,338
+345,660
| +894% | +$83M |
|
191
PUT
Costco
COST
$420B
| $92.4M | 0.12% |
107,200
+71,500
| +200% | +$64.8M |
|
192
CALL
UnitedHealth
UNH
$350B
| $91.2M | 0.12% |
276,300
-73,200
| -21% | -$24.8M |
|
|
NGD
193
DELISTED
New Gold Inc
NGD
| $91.2M | 0.12% |
10,467,113
+9,479,976
| +960% | +$71.4M |
|
194
Alaska Air
ALK
$4.51B
| $89.9M | 0.11% |
1,787,099
+811,147
| +83% | +$37.5M |
|
195
Voya Financial
VOYA
$8.86B
| $89.7M | 0.11% |
1,203,687
-506,704
| -30% | -$36.9M |
|
196
PUT
Applied Materials
AMAT
$391B
| $89.4M | 0.11% |
347,900
-71,500
| -17% | -$17.1M |
|
197
Tyson Foods
TSN
$20.6B
| $89.4M | 0.11% |
1,524,925
+1,431,069
| +1,525% | +$78.6M |
|
198
Consolidated Edison
ED
$39.3B
| $89M | 0.11% |
+896,147
| New | +$88.9M |
|
199
PUT
State Street SPDR S&P Retail ETF
XRT
$491M
| $88.6M | 0.11% |
1,038,400
-249,000
| -19% | -$20.9M |
|
200
Nucor
NUE
$55.3B
| $86.8M | 0.11% |
532,134
+77,984
| +17% | +$11.7M |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.